Watch this on YouTube.
Supplements like Memory Lift are often driven more by marketing than by what’s actually inside the bottle. They lean heavily on vague, weak, or non-evidence-based claims and borrow the language of science to sell the idea of a “breakthrough” brain formula. In some cases, the product being promoted isn’t even the one you end up buying. A slick landing page advertises one supplement, but the purchase links quietly redirect you to a cheaper, generic version because it’s easier to source and more profitable. Over time, this kind of mass marketing attracts countless copycats, making it nearly impossible to track down any supposed “original” product online.
Putting the marketing hype aside, let’s take a closer look at the ingredients most commonly found in Memory Lift–style formulas and ask a simple question: do any of them actually have solid scientific evidence behind them when it comes to improving memory or cognitive function?
Typical Ingredients of Memory Lift
DMAE (Dimethylaminoethanol)
DMAE, or dimethylaminoethanol, is a compound related to choline that was once sold as a prescription drug for managing ADHD in children. However, regulators eventually required stronger, more rigorous studies because the existing research was inconsistent and unconvincing. Since DMAE is a naturally occurring compound that can’t be patented, the manufacturer had little incentive to fund expensive clinical trials. Instead of being properly studied, the drug was discontinued.
As newer and more effective ADHD treatments became available, DMAE fell out of clinical use entirely. Research has also shown no meaningful benefit for dementia-related conditions, including Alzheimer’s disease, and there’s no good evidence that it improves memory or brain function in healthy people. While DMAE has an interesting history, the science simply doesn’t support its use today.
Bacopa Monnieri
Bacopa monnieri is an herb used in traditional Ayurvedic medicine and is one of the few ingredients in these formulas with some supportive evidence. A large review of studies suggests that taking around 300 to 600 milligrams per day for at least 12 weeks may lead to small improvements in certain memory tasks in healthy adults.
However, those benefits don’t appear in people with neurological conditions. Studies in individuals with Alzheimer’s disease, mild cognitive impairment, or Parkinson’s disease have found no meaningful improvements in memory, cognition, or quality of life. It’s also worth noting that the doses used in studies showing benefits are often much higher than what products like Memory Lift typically contain.
Ginkgo Biloba
Ginkgo biloba has been studied extensively for brain health, with mixed results. Some trials suggest that standardized ginkgo extracts taken daily for several weeks may slightly improve memory or attention in healthy adults. Many other studies, however, find no meaningful benefit at all.
Where ginkgo does seem to help is in people who already have cognitive impairment, particularly those with certain types of dementia. Even then, the improvements are modest and linked to specific standardized extracts, not the generic ginkgo powders commonly found in supplements. Importantly, ginkgo does not prevent dementia or slow its progression.
Huperzine A
Huperzine A works by blocking the enzyme that breaks down acetylcholine, a neurotransmitter involved in memory and attention. By doing so, it increases acetylcholine levels in the brain. In people with Alzheimer’s disease, this mechanism can lead to small improvements in memory and behavior. In healthy adults, however, the evidence shows little to no benefit.
Drugs and supplements that boost acetylcholine tend to help only when there’s an existing deficiency. If brain function is already normal, increasing acetylcholine doesn’t translate into better memory or sharper thinking.
Lion’s Mane Mushroom
Lion’s Mane mushroom has gained popularity for its supposed brain-boosting effects. Some small studies suggest it may offer modest benefits for older adults with mild cognitive impairment or early Alzheimer’s disease, but only at relatively high doses taken consistently for months. Even then, the benefits tend to disappear once supplementation stops.
In healthy people, the evidence is far less convincing. Studies in younger adults show no improvement in mental performance, and results in older adults without diagnosed impairment are inconsistent. Once again, the doses used in studies showing any effect are far higher than what Memory Lift contains.
Phosphatidylserine
Phosphatidylserine is a fat that plays a role in the structure of brain cells. Research suggests it may help with attention, memory, and verbal fluency in people experiencing age-related cognitive decline or mild impairment. Short-term improvements have also been seen in people with Alzheimer’s disease, but these effects tend to fade after a few months and do not slow disease progression.
In healthy individuals, the evidence for benefit is weak, and studies that do show positive effects typically use doses around 300 milligrams per day—much higher than what Memory Lift is likely to provide.
Is Memory Lift Effective?
So, is Memory Lift effective? In short, no. This is not a supplement I would recommend. Beyond the issue of underdosed ingredients, there’s a real concern that the product you receive may not even contain what’s advertised. While a few of these compounds may have limited value in very specific situations, you’re far better off choosing individual supplements with clearly labeled ingredients and evidence-based dosing, so you actually know what you’re taking and why.
Overall rating
Rating Memory Lift by effectiveness for improving cognition, I’m giving it a D. The doses are likely too low to provide meaningful benefits.
Rating it by cost, I’m giving it a D. The formula can be easily replicated with higher-quality ingredients at a fraction of the price.
Rating it for safety, I’m giving it a C. There are too many copycat products and too much uncertainty around what you’re actually getting.
Overall rating, I’m giving an F. I would recommend you stay away from it.
Top alternatives to Memory Lift
- Bacopa – 1 to 2 caps / day
- Ginkgo (Egb 761) – 1 cap / day
- Ginkgo (generic) – 1 cap / day
- L-Theanine – 2 to 4 lozenge / day
- Phosphatidylserine (generic) – 1 to 3 caps / day
- Phosphatidylserine (Neuriva) – 1 cap / day
Learn more about
Citations
Baba Y, Inagaki S, Nakagawa S, Kaneko T, Kobayashi M, Takihara T. Effects of l-Theanine on Cognitive Function in Middle-Aged and Older Subjects: A Randomized Placebo-Controlled Study. J Med Food. 2021 Apr;24(4):333-341. doi: 10.1089/jmf.2020.4803. Epub 2021 Mar 22. PMID: 33751906; PMCID: PMC8080935.
Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 2007;167(1):21-30. doi:10.1001/archinte.167.1.21
Beck SM, Ruge H, Schindler C, et al. Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment – a randomized double-blind placebo-controlled trial. Hum Psychopharmacol. 2016;31(3):227-242. doi:10.1002/hup.2534
Camfield DA, Stough C, Farrimond J, Scholey AB. Acute effects of tea constituents L-theanine, caffeine, and epigallocatechin gallate on cognitive function and mood: a systematic review and meta-analysis. Nutr Rev. 2014 Aug;72(8):507-22. doi: 10.1111/nure.12120. Epub 2014 Jun 19. PMID: 24946991.
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano). 1993;5(2):123-133. doi:10.1007/BF03324139
Crook T, Petrie W, Wells C, Massari DC. Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull. 1992;28(1):61-66.
Dartigues JF, Carcaillon L, Helmer C, Lechevallier N, Lafuma A, Khoshnood B. Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort. J Am Geriatr Soc. 2007;55(3):395-399. doi:10.1111/j.1532-5415.2007.01084.x
De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. 2003;25(1):178-193. doi:10.1016/s0149-2918(03)90023-3
Devita M, Masina F, Mapelli D, Anselmi P, Sergi G, Coin A. Acetylcholinesterase inhibitors and cognitive stimulation, combined and alone, in treating individuals with mild Alzheimer’s disease. Aging Clin Exp Res. 2021;33(11):3039-3045. doi:10.1007/s40520-021-01837-8
Einöther SJ, Martens VE, Rycroft JA, De Bruin EA. L-theanine and caffeine improve task switching but not intersensory attention or subjective alertness. Appetite. 2010 Apr;54(2):406-9. doi: 10.1016/j.appet.2010.01.003. Epub 2010 Jan 15. PMID: 20079786.
Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer’s disease. Am J Psychiatry. 1981 Jul;138(7):970-2. doi: 10.1176/ajp.138.7.970. PMID: 7020434.
Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2012;29(1):133-149. doi:10.3233/JAD-2012-111739
Foxe JJ, Morie KP, Laud PJ, Rowson MJ, de Bruin EA, Kelly SP. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task. Neuropharmacology. 2012 Jun;62(7):2320-7. doi: 10.1016/j.neuropharm.2012.01.020. Epub 2012 Feb 2. PMID: 22326943.
Fünfgeld EW, Baggen M, Nedwidek P, Richstein B, Mistlberger G. Double-blind study with phosphatidylserine (PS) in parkinsonian patients with senile dementia of Alzheimer’s type (SDAT). Prog Clin Biol Res. 1989;317:1235-1246.
Grozier CD, Alves VA, Killen LG, Simpson JD, O’Neal EK, Waldman HS. Four Weeks of Hericium erinaceus Supplementation Does Not Impact Markers of Metabolic Flexibility or Cognition. Int J Exerc Sci. 2022;15(2):1366-1380. Published 2022 Oct 1.
Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer’s disease. A neuropsychological, EEG, and PET investigation. Dementia. 1994;5(2):88-98. doi:10.1159/000106702
Hidese S, Ogawa S, Ota M, Ishida I, Yasukawa Z, Ozeki M, Kunugi H. Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients. 2019 Oct 3;11(10):2362. doi: 10.3390/nu11102362. PMID: 31623400; PMCID: PMC6836118.
Ihl R, Tribanek M, Bachinskaya N; GOTADAY Study Group. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer’s disease and vascular dementia: results from a randomised controlled trial. Pharmacopsychiatry. 2012;45(2):41-46. doi:10.1055/s-0031-1291217
Kennedy DO, Scholey AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl). 2000;151(4):416-423. doi:10.1007/s002130000501
Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, Limpeanchob N, Norman Scholfield C. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol. 2014;151(1):528-535. doi:10.1016/j.jep.2013.11.008
Laws KR, Sweetnam H, Kondel TK. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis. Hum Psychopharmacol. 2012;27(6):527-533. doi:10.1002/hup.2259
Liao Z, Cheng L, Li X, Zhang M, Wang S, Huo R. Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer’s Disease. Clin Neuropharmacol. 2020;43(4):93-99. doi:10.1097/WNF.0000000000000394
Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther. 1975 May;17(5):534-40. doi: 10.1002/cpt1975175534. PMID: 1092513.
Markun S, Gravestock I, Jäger L, Rosemann T, Pichierri G, Burgstaller JM. Effects of Vitamin B12 Supplementation on Cognitive Function, Depressive Symptoms, and Fatigue: A Systematic Review, Meta-Analysis, and Meta-Regression. Nutrients. 2021;13(3):923. Published 2021 Mar 12. doi:10.3390/nu13030923
Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. doi:10.1002/ptr.2634
Prabhakar S, Vishnu VY, Modi M, et al. Efficacy of Bacopa Monnieri (Brahmi) and Donepezil in Alzheimer’s Disease and Mild Cognitive Impairment: A Randomized Double-Blind Parallel Phase 2b Study. Ann Indian Acad Neurol. 2020;23(6):767-773. doi:10.4103/aian.AIAN_610_19
Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125-131. doi:10.2220/biomedres.40.125
Santos AFD, Souza MMQ, Amaral EC, et al. Bacopa monnieri in Patients with Parkinson’s Disease: A Pilot Study. J Med Food. 2023;26(2):114-119. doi:10.1089/jmf.2022.0106
Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B. An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. Isr J Psychiatry Relat Sci. 2000;37(4):302-307.
Swart KM, Ham AC, van Wijngaarden JP, et al. A Randomized Controlled Trial to Examine the Effect of 2-Year Vitamin B12 and Folic Acid Supplementation on Physical Performance, Strength, and Falling: Additional Findings from the B-PROOF Study. Calcif Tissue Int. 2016;98(1):18-27. doi:10.1007/s00223-015-0059-5
Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-474. doi:10.1159/000310330
van der Zwaluw NL, Dhonukshe-Rutten RA, van Wijngaarden JP, et al. Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT. Neurology. 2014;83(23):2158-2166. doi:10.1212/WNL.0000000000001050
Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN. Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr. 2010;10:14. Published 2010 Mar 17. doi:10.1186/1471-2318-10-14
Yang G, Wang Y, Tian J, Liu JP. Huperzine A for Alzheimer’s disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013;8(9):e74916. Published 2013 Sep 23. doi:10.1371/journal.pone.0074916
Yang M, Xu DD, Zhang Y, Liu X, Hoeven R, Cho WC. A systematic review on natural medicines for the prevention and treatment of Alzheimer’s disease with meta-analyses of intervention effect of ginkgo. Am J Chin Med. 2014;42(3):505-521. doi:10.1142/S0192415X14500335
Yesavage JA, Friedman L, Ashford JW, et al. Acetylcholinesterase inhibitor in combination with cognitive training in older adults. J Gerontol B Psychol Sci Soc Sci. 2008;63(5):P288-P294. doi:10.1093/geronb/63.5.p288
Young LM, Gauci S, Arnoldy L, et al. Investigating the Effects of a Multinutrient Supplement on Cognition, Mood and Biochemical Markers in Middle-Aged Adults with ‘Optimal’ and ‘Sub-Optimal’ Diets: A Randomized Double Blind Placebo Controlled Trial. Nutrients. 2022;14(23):5079. Published 2022 Nov 29. doi:10.3390/nu14235079
See also
- OxyShred Hardcore Review
OxyShred Hardcore is basically a flavored caffeine supplement, with many ingredients that are ineffective or underdosed. - Mars Men Review
Testosterone boosters like Mars Men may slightly raise testosterone, but mainly in older men who already have low levels. - CeraVe Moisturizers Review
CeraVe moisturizers use ceramides, which are great for repairing troubled skin. If your skin is already healthy, the benefits are milder. - Hormify Review
Hormify is a weak multivitamin with poorly studied libido herbs, and it’s unlikely to help with hormones or weight loss. - Burn Peak Review
Burn Peak, like most BHB supplements, doesn’t actually do anything helpful for weight loss, metabolism, or overall health.